Max Robotics — Global Service Robot Directory + US Certification

About

Jason Moffat is a leading figure in functional genomics and proteomics, whose work has fundamentally reshaped how researchers study gene function and protein tools. His key research areas include the development of high-throughput platforms for recombinant antibody generation and the systematic mapping of genetic interactions in human cells. Moffat’s major contributions lie in creating scalable, renewable resources for the scientific community—most notably, an industrialized platform that produced validated recombinant antibodies for 346 transcription factors, a breakthrough cited over 120 times for its promise of permanent, high-quality reagents. This work addresses a critical bottleneck in biology, replacing unreliable commercial antibodies with a robust, reproducible alternative. Beyond antibodies, Moffat is renowned for pioneering CRISPR-based screens to dissect genetic networks, revealing how genes cooperate in health and disease. His impact is reflected in hundreds of citations across his portfolio, with his tools and datasets becoming standard references in labs worldwide. Notable achievements include leading large-scale collaborative projects that bridge genomics and cell biology, earning him recognition as a transformative force in open science. For students and researchers, Moffat’s career exemplifies how engineering biological platforms can accelerate discovery from bench to bedside.